Regulation of Gelatinase Activity in Mice with Targeted Inactivation of Components of the Plasminogen/Plasmin System
- 1 January 1998
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 79 (06) , 1171-1176
- https://doi.org/10.1055/s-0037-1615036
Abstract
To investigate a potential physiological role of the plasminogen/ plasmin system in activation of the matrix metalloproteinase (MMP) system, the distribution of latent and active MMP-2 (gelatinase A) or MMP-9 (gelatinase B) was monitored in aorta extracts and in serum-free conditioned cell culture medium obtained from wild-type (WT) mice and from mice with deficiency of tissue-type plasminogen activator (t-PA–/–), urokinase-type plasminogen activator (u-PA–/–), plasminogen activator inhibitor-1 (PAI-1–/–) or plasminogen (Plg–/–). In aorta extracts, the contribution of active MMP-2 to the total MMP-2 level ranged between 7 and 16% for the different genotypes, whereas active MMP-9 was not detected. The contribution of active 58 kDa MMP-2 to the total MMP-2 level (active plus latent) ranged between 14 and 29% (mean of 3 experiments) for fibroblasts of the different genotypes, and between 18 and 32% for smooth muscle cells, and was relatively constant in time (7-72 h). The contribution of active 83 kDa MMP-9 to the total MMP-9 level ranged between 15 and 29% for fibroblasts of the different genotypes and was relatively constant in time (24-72 h); corresponding values were 17 to 57% for smooth muscle cells, with the exception of Plg–/– smooth muscle cells which had undetectable levels of active MMP-9. Addition of plasmin(ogen) to the cell culture medium of fibroblasts did not significantly affect the distribution of active and latent MMP-2, but resulted in an approximately two-fold enhancement of the contribution of active MMP-9. In macrophages of Plg–/– mice, active MMP-9 was detected only when the cells were cultured in the presence of plasminogen. These data indicate that activation of proMMP-2 occurs independently of the physiological plasminogen activators and of plasmin(ogen) in all the cell types evaluated. Activation of proMMP-9 was enhanced in the presence of plasmin(ogen), but active MMP-9 was also detected in fibroblasts of Plg–/– mice, indicating that in vivo activation may occur via plasmin(ogen)-independent mechanisms.Keywords
This publication has 21 references indexed in Scilit:
- Activation of Progelatinase B (proMMP‐9) by Active Collagenase‐3 (MMP‐13)European Journal of Biochemistry, 1997
- Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactantsThe EMBO Journal, 1997
- Proteolytic remodeling of extracellular matrixCurrent Opinion in Cell Biology, 1995
- A matrix metalloproteinase expressed on the surface of invasive tumour cellsNature, 1994
- Physiological consequences of loss of plasminogen activator gene function in miceNature, 1994
- Proteolytic processing of the 72,000-Da type IV collagenase by urokinase plasminogen activatorExperimental Cell Research, 1992
- Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin)Biochemistry, 1990
- Metalloproteinases and their inhibitors in matrix remodelingTrends in Genetics, 1990
- Tissue cooperation in a proteolytic cascade activating human interstitial collagenase.Proceedings of the National Academy of Sciences, 1989
- Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activationBiochemical Journal, 1977